IRIDEX CORP — Form 8-K
Filed November 17, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
IRIDEX reported Q3 2026 revenue of $10.2M (vs. $12.5M YoY), driven by weak international demand and distributor inventory correction. Retina revenue fell to $5.1M from $6.7M; Cyclo G6 probes sold 11,900 units vs. 14,900 YoY. Full-year 2026 guidance cut to $46–48M from $51–53M. Gross margin improved to 42.4% (vs. 32.1% YoY, excluding prior-year write-off). Cash declined $1M to $3.7M; net loss $1.4M ($0.08/share). HQ relocation expected to yield ~$600K annualized savings.
Why this rating
19% revenue miss + 9% FY guidance cut are material for $14.2M market-cap company. Cash runway shrinking; margin gains offset by volume declines and ongoing losses.
Tradability signal
NO TRADE
No trade: only ~$31k traded in the last 30 min — too illiquid to enter and exit. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $0.48 ▼ 3.56% | at our read · unknown $0.50 | +10 min · unknown $0.50 ▼ 0.18% | +30 min · unknown $0.47 ▼ 6.00% | +1 hr · unknown $0.48 ▼ 4.00% | +4 hrs · unknown $0.51 ▲ 2.20% |
The stock had already moved +3.69% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.